Do Interventions Improve Symptoms Among ICU Surrogates Facing End-of-Life Decisions? A Prognostically-Enriched Systematic Review and Meta-Analysis
- PMID: 35997501
- PMCID: PMC10193371
- DOI: 10.1097/CCM.0000000000005642
Do Interventions Improve Symptoms Among ICU Surrogates Facing End-of-Life Decisions? A Prognostically-Enriched Systematic Review and Meta-Analysis
Abstract
Objectives: Evaluate the efficacy of interventions to improve symptoms for ICU surrogates at highest risk of developing psychologic distress: those facing end-of-life care decisions.
Data sources: MEDLINE, CINAHL, PsycInfo, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched through April 16, 2022.
Study selection: Following an a priori protocol, randomized trials of interventions delivered to surrogates of adult ICU patients who died or had high likelihood of mortality evaluating surrogate symptoms were identified.
Data extraction: Two reviewers performed screening and data extraction and assessed risk of bias (Cochrane Risk of Bias [RoB] 2 tool). Trials were eligible for meta-analysis if group mean symptom scores were provided at 3 or 6 months. Pooled effects were estimated using a random effects model. Heterogeneity was assessed (Cochrane Q, I2 ). Certainty of evidence was assessed (Grading of Recommendations Assessment, Development and Evaluation).
Data synthesis: Of 1,660 records, 10 trials met inclusion criteria representing 3,824 surrogates; eight were included in the meta-analysis. Overall RoB was rated Some Concerns. Most ( n = 8) interventions focused on improving communication and enhancing psychologic support in the ICU. All trials measured anxiety, depression, and posttraumatic stress. Significant improvement was seen at 3 months (depression, mean difference [MD], -0.68; 95% CI, -1.14 to -0.22, moderate certainty; posttraumatic stress, standardized MD, -0.25; 95% CI, -0.49 to -0.01, very low certainty) and 6 months (anxiety, MD, -0.70; 95% CI, -1.18 to -0.22, moderate certainty). Sensitivity analyses suggest significant findings may be unstable. Subgroup analyses demonstrated differences in effect by trial location, interventionist, and intervention dose.
Conclusions: Communication and psychological support interventions in the ICU yielded small but significant improvement in psychological symptoms with moderate to very low certainty evidence in a prognostically-enriched sample of ICU surrogates facing end-of-life care decisions. A new approach to interventions that extend beyond the ICU may be needed.
Copyright © 2022 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Conflict of interest statement
Ms. DeForge’s institution received funding from the National Center for Advancing Translational Sciences; she received funding from Society of Critical Care Medicine (2022 Critical Care Congress Scholarship Grant). Ms. DeForge and Dr. Baldwin received support for article research from the National Institutes of Health. Dr. George received funding from AstraZeneca, Genetech, Sanofi Regeneron, and Teva. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Figures
References
-
- Davidson JE, Aslakson RA, Long AC, et al.: Guidelines for family-centered care in the neonatal, pediatric, and adult ICU. Crit Care Med 2017; 45:103–128 - PubMed
-
- Johnson CC, Suchyta MR, Darowski ES, et al.: Psychological sequelae in family caregivers of critically III intensive care unit patients. A systematic review. Ann Am Thorac Soc 2019; 16:894–909 - PubMed
-
- Azoulay E, Pochard F, Kentish-Barnes N, et al.; FAMIREA Study Group: Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med 2005; 171:987–994 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous